Tina M. Mayer, MD
Assistant Professor of Medicine, Medical Oncology
Cancer Institute of New Jersey
Assistant: Huberta Faustin
Research Program Alignment
Membership Type: Associate - CCSG
- Clinical trials in the areas of genitourinary and primary brain tumors.
Anton K, Baehring J, Mayer T. Glioblastoma Multiforme: Overview of current treatments and future perspectives. Hematol Oncol Clin N Am, 2012 Aug;26(4):825-53. Epub 2012 May 11.
Kathpal M, Mayer T, et al. Importance of Initial Aggressive Treatment for Pineal Parenchymal Tumor of Intermediate Differentiation: A Case Report and Review of Literature. Practical Radiation Oncology, 2012, Article in Press.
Kluger H, . . .Mayer T … et al. Plasma markers for identifying patients with metastatic melanoma. Clinical Cancer Research; April 15, 2011: 17; 2417.
Chao HH, Mayer T, Concato J, et al. Prostate cancer, comorbidity, and participation in randomized controlled trials of therapy. J Investig Med 2010, Jan 12 (epub ahead of print)
Mayer, T., Lacy, J., Baehring, J. A single institution’s experience with bevacizumab in combination with cytotoxic chemotherapy in progressive malignant glioma. Clinical Medicine: Oncology 2008;2:455-459.Meyer T, Howland HC. How large is the optic disc? Systematic errors in fundus cameras and topographers. Ophthal Physiol Opt 2001;21(2):139-150.